Significance of plasma levels of pigment epithelium-derived factor as determined by multidetector row computed tomography in patients with mild chronic kidney disease and/or coronary artery disease

Journal of International Medical Research

Volumn 39, Issue 3, 2011, Pages 880-890

  Shiga, Y ^a   Miura, S ^a   Mitsutake, R ^a   Yamagishi, S ^b   Saku, K ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic kidney disease; Coronary artery disease; Multidetector row computed tomography; Pigment epithelium derived factor

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PIGMENT EPITHELIUM DERIVED FACTOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; HYPERURICEMIA; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX; SUBCUTANEOUS FAT; THORAX PAIN;

EID: 80052250094     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900322     Document Type: Article

References (31)

1. Tombran-Tink J, Chader GG, Johnson LV: PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 1991; 53: 411-414.
2. Becerra SP, Sagasti A, Spinella P, et al: Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop. J Biol Chem 1995; 270: 25992-25999.
3. Wang JJ, Zhang SX, Lu K, et al: Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy. Diabetes 2005; 54: 243-250.
4. Yoshida T, Yamagishi S, Nakamura K, et al: Pigment epithelium-derived factor (PEDF) blocks the interleukin-6 signaling to C-reactive protein expression in Hep3B cells by suppressing Rac-1 activation. Life Sci 2006; 79: 1981-1987.
5. Wang JJ, Zhang SX, Mott R, et al: Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy. Am J Physiol Renal Physiol 2008; 294: F1166-F1173.
6. Yamagishi S, Nakamura K, Matsui T, et al: Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J Biol Chem 2006; 281: 20213-20220.
7. Nakamura K, Yamagishi S, Matsui T, et al: Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation. Am J Pathol 2007; 170: 2159-2170.
8. Matsumoto K, Ishikawa H, Nishimura D, et al: Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma. Hepatology 2004; 40: 252-259.
9. Zvonic S, Lefevre M, Kilroy G, et al: Secretome of rimary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis. Mol Cell Proteomics 2007; 6: 18-28.
10. Yamagishi S, Adachi H, Abe A, et al: Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab 2006; 91: 2447-2450.
11. Nakamura K, Yamagishi S, Adachi H, et al: Serum levels of pigment epithelium-derived factor (PEDF) are an independent determinant of insulin resistance in patients with essential hypertension. Int J Cardiol 2010; 143: 96-98.
12. Motomiya Y, Yamagishi S, Adachi H, et al: Increased serum concentrations of pigment epithelium-derived factor in patients with end-stage renal disease. Clin Chem 2006; 52: 1970-1971.
13. Mitsutake R, Miura S, Kawamura A, et al: Are metabolic factors associated with coronary artery stenosis on MDCT? Circ J 2009; 73: 132-138.
14. Hoffmann U, Moselewski F, Cury RC, et al: Predictive value of 16-slice multidetector spiral computed tomography to detect significant obstructive coronary artery disease in patients at high risk for coronary artery disease: patient-versus segment-based analysis. Circulation 2004; 110: 2638-2643.
15. Leschka S, Alkadhi H, Plass A, et al: Accuracy of MSCT coronary angiography with 64-slice technology: first experience. Eur Heart J 2005; 26: 1482-1487.
16. Budoff MJ, Achenbach S, Blumenthal RS, et al: Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association. Circulation 2006; 114: 1761-1791.
17. Mitsutake R, Niimura H, Miura S, et al: Clinical significance of the coronary calcification score by multidetector row computed tomography for the evaluation of coronary stenosis in Japanese patients. Circ J 2006; 70: 1122-1127.
18. American Diabetes Association: Screening for type 2 diabetes. Diabetes Care 2004; 27(suppl 1): S11-S14.
19. Arita Y, Kihara S, Ouchi N, et al: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
20. Agatston AS, Janowitz WR, Hildner FJ, et al: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832.
21. Dodge JT, Brown BG, Bolson EL, et al: Intrathoracic spatial location of coronary segments on the normal human heart. Circulation 1988; 78: 1167-1180.
22. Imai E, Horio M, Watanabe T, et al: Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009; 13: 621-630.
23. Tombran-Tink J, Mazuruk K, Rodriguez IR, et al: Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol Vis 1996; 2: 11.
24. Sawant S, Aparicio S, Tink AR, et al: Regulation of factors controlling angiogenesis in liver development: a role for PEDF in the formation and maintenance of normal vasculature. Biochem Biophys Res Commun 2004; 325: 408-413.
25. Matsumoto K, Ishikawa H, Nishimura D, et al: Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma. Hepatology 2004; 40: 252-259.
26. Maeda K, Okubo K, Shimomura I, et al: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996; 221: 286-289.
27. Arita Y, Kihara S, Ouchi N, et al: Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002; 105: 2893-2898.
28. Kratchmarova I, Kalume DE, Blagoev B, et al: A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 2002; 1: 213-222.
29. Matsuzawa Y: Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006; 3: 35-42.
30. Matsuyama K, Ogata N, Matsuoka M, et al: Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy. Mol Vis 2008; 14: 992-996.
31. Ropers D, Rixe J, Anders K, et al: Usefulness of multidetector row computed tomography with 64-× 0.6-mm collimation and 330-ms rotation for the noninvasive detection of significant coronary artery stenoses. Am J Cardiol 2006; 97: 343-348.